Conditioning Agent
METHIONYL R-CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1 HEXAPEPTIDE-40
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A fusion recombinant peptide combining botulinum-source sequences with hexapeptide-40, raising significant safety concerns due to neurotoxic protein heritage.
A single-chain recombinant fusion peptide combining r-Clostridium Botulinum Polypeptide-1 and Hexapeptide-40 with a methionine initiation codon, produced in E. coli. Clostridium botulinum is the source of botulinum neurotoxin, one of the most potent biological toxins known. While this recombinant version is a peptide fragment, the botulinum-derived component introduces serious neurotoxicity concerns. Under EU Regulation EC 1223/2009, such neuroactive ingredients require extreme caution and are effectively restricted in cosmetic products.
Function
Skin benefits
- Skin protection (claimed function only)
Known concerns
- Clostridium botulinum-derived component poses neurotoxicity risk
- Significant safety concerns from botulinum protein heritage
- EU regulatory scrutiny likely due to neuroactive nature
- Potential for severe immune reactions
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related conditioning agents
Check your shelf
Find METHIONYL R-CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1 HEXAPEPTIDE-40 in your products.
Scan any cosmetic product with LuxSense to see if it contains METHIONYL R-CLOSTRIDIUM BOTULINUM POLYPEPTIDE-1 HEXAPEPTIDE-40 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.